CBIZ, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBZ research report →
Range $45 – $55
Price Chart
About the company
CBIZ, Inc. is a professional services firm that delivers a broad spectrum of financial, insurance, and advisory solutions across the United States and Canada. The company's operations are organized into three principal divisions: Financial Services, Benefits and Insurance Services, and National Practices.
- CEO
- Jerome Grisko Jr.
- IPO
- 1995
- Employees
- 9,500
- HQ
- Independence, OH, US
Get TickerSpark's AI analysis on CBZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.03B
- P/E
- 21.99
- Fwd P/E
- 13.18
- PEG
- 0.35
- P/S
- 1.09
- P/B
- 1.73
- EV/EBITDA
- 14.05
- Div Yield
- 0.00%
- Gross Margin
- 13.03%
- Op Margin
- 8.49%
- Net Margin
- 5.33%
- ROE
- 7.97%
- ROIC
- 4.14%
Latest fiscal year · YoY change
- Revenue
- $2.76B+52.1%
- Gross Profit
- $355.39M+94.8%
- Op Income
- $234.01M
- Net Income
- $115.44M+181.3%
- EPS
- $1.83+134.6%
- OCF Growth
- +55.6%
- FCF Growth
- +58.4%
- 52W High
- $55.56
- 52W Low
- $24.29
- 50D MA
- $54.72
- 200D MA
- $39.78
- Beta
- 0.88
- RSI (14)
- 68
- Avg Volume
- 1.27M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CBIZ said first-quarter 2026 results were in line with expectations, with modest revenue growth, margin improvement, stronger free cash flow and a raised EPS outlook as integration headwinds eased.· July 29, 2026
- Revenue rose 1.3% year over year to $849 million; organic revenue growth was 1% and adjusted EBITDA increased to $244 million.
- Adjusted diluted EPS was $2.50, up 7% from $2.33, helped by synergies, scale and a lower share count.
- Free cash flow improved $64 million year over year, aided by $53 million of final purchase price adjustment proceeds, and the company repurchased about $63 million of stock through the end of April.
- Management said first-quarter organic growth improved through the quarter and expects growth to accelerate as integration and client-attrition impacts fade.
- Full-year guidance was reaffirmed for revenue and adjusted EBITDA, while adjusted EPS was raised to $4.00-$4.10 and free cash flow guidance stayed at $270 million-$290 million.
CBIZ reported first-quarter 2026 revenue of $849 million, up 1.3% year over year, with organic revenue growth of 1%. Adjusted EBITDA was $244 million, up $3 million year over year, and adjusted EBITDA margin increased by 10 basis points. Adjusted diluted EPS was $2.50 versus $2.33 a year ago, up 7%. Free cash flow improved $64 million year over year, primarily due to $53 million of proceeds from the final purchase price adjustment. For 2026, the company reaffirmed revenue guidance of $2.8 billion to $2.9 billion and free cash flow guidance of $270 million to $290 million. Adjusted EBITDA guidance was updated to $465 million to $475 million, and adjusted EPS was raised to $4.00 to $4.10, assuming a weighted average fully diluted share count of about 60.5 million.
Jerry Grisko said CBIZ entered 2026 with a clear plan and delivered performance that was in line with expectations, with year-over-year growth in revenue, profitability and free cash flow. He emphasized that the company is now operating as one integrated platform, with better organic growth progression through the quarter, improving market conditions and a stronger go-to-market model built around 12 industry verticals, cross-selling and AI. His tone was confident and upbeat, especially on the company’s ability to exit the year at its mid-single-digit organic growth target and return to its long-term algorithm.
Brad Lakhia highlighted the key financial drivers: revenue of $849 million, adjusted EBITDA of $244 million, adjusted diluted EPS of $2.50, and free cash flow improvement of $64 million year over year. He said the company used strong cash generation to fund about $63 million in share repurchases through the end of April, while net leverage improved to approximately 3.4x from 3.9x a year earlier. He also noted the 2026 guidance changes: revenue unchanged at $2.8 billion-$2.9 billion, adjusted EBITDA updated to $465 million-$475 million, adjusted EPS raised to $4.00-$4.10, and free cash flow unchanged at $270 million-$290 million.
Analysts focused on AI’s potential to pressure pricing, whether clients could unbundle services, producer hiring in Benefits and Insurance, repurchase pace, pricing trends, macro conditions and integration progress. Management argued that regulated professional services require expertise and judgment that clients cannot easily replicate with AI tools, and said AI should strengthen CBIZ’s competitive position versus smaller rivals that cannot invest at the same scale. On B&I, management reiterated a goal of about 15% year-over-year producer growth in 2026; on buybacks, they said repurchases will remain active and opportunistic because they view the stock as undervalued and free cash flow as strong.
The call presented a clear case that integration is starting to work: organic growth improved sequentially, onboarding has improved and management expects the prior attrition/integration drag to fade in the second half. CBIZ also pointed to favorable advisory demand, a healthy pipeline, strong recurring revenue, active share repurchases and early AI and offshore efficiency gains as supports for margin and growth.
The main risks discussed were still integration-related: temporary client attrition, productivity disruptions from the first busy season as an integrated company, and a roughly 200 basis-point drag to first-quarter organic growth. Benefits and Insurance revenue was down 4% year over year due to tough comps, contingent commission declines and one producer departure, and management said some growth depends on market conditions staying favorable through the year.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.6%
- Shares Outstanding
- 55.11M
- Float Shares
- 48.83M
of shares held by institutions
269 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CBZ, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Sell | Jun 30, 26 | Filing → |
| Josh GottheimerHouse · NJ05 | Buy | Apr 6, 26 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Mar 5, 26 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Apr 9, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Mar 24, 25 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Mar 7, 24 | Filing → |
| Josh GottheimerHouse · NJ05 | Buy | Feb 23, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 5.29M | ▲ 321.67K |
| Vanguard Group Inc | 4.84M | ▼ 50.80K |
| Bank Of Montreal /Can/ | 3.27M | ▼ 183.47K |
| 22c Capital LLC | 3.20M | 0 |
| Fmr LLC | 3.15M | ▼ 4.90M |
| Balyasny Asset Management L.P. | 2.67M | ▲ 2.63M |
| Vanguard Capital Management LLC | 2.27M | ▲ 8.09K |
| Vanguard Portfolio Management LLC | 2.22M | ▼ 34.19K |
| Fil Ltd | 1.52M | ▲ 1.52M |
| First Trust Capital Management L.P. | 1.36M | ▲ 1.36M |
| Geode Capital Management, LLC | 1.25M | ▼ 9.58K |
| State Street Corp | 1.24M | ▼ 6.88K |
Held by 144 ETFs
Biggest fund positions in CBZ by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 2, 26 | Mangan Michael T. | sell | 7,633.408 |
| Nov 2, 26 | Lakhia Brad S. | sell | 141,019.955 |
| Nov 2, 26 | Kouzelos Michael P | sell | 389,718 |
| Nov 2, 26 | GRISKO JEROME P | sell | 62,920 |
| Nov 2, 26 | YOUNG RODNEY A | sell | 15,361 |
| Nov 2, 26 | YOUNG RODNEY A | sell | 50,000 |
| Nov 2, 26 | MARABITO RICHARD T | sell | 18,887 |
| Nov 2, 26 | MARABITO RICHARD T | sell | 50,000 |
| Nov 2, 26 | SLOTKIN TODD J | sell | 57,229 |
| Nov 2, 26 | SHERMAN A HAAG | sell | 47,771 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CBZ coverage
Recent articles, reports, and earnings notes.
No research on CBZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBZ report →Here is Why Growth Investors Should Buy CBIZ (CBZ) Now
zacks.com · Nov 3
CBIZ Benefits & Insurance Services Launches as Independent Company Backed by New Mountain Capital
businesswire.com · Nov 2
Grant Thornton Advisors completes acquisition of CBIZ
businesswire.com · Nov 2
Should Value Investors Buy CBIZ (CBZ) Stock?
zacks.com · Oct 27
CBIZ Stockholders Approve Viking Merger Agreement in Preliminary Vote
marketbeat.com · Oct 27
CBZ vs. EFX: Which Stock Should Value Investors Buy Now?
zacks.com · Oct 21
CBIZ (CBZ) Lags Q3 Earnings and Revenue Estimates
zacks.com · Oct 19
CBIZ (NYSE:CBZ) Releases Earnings Results
defenseworld.net · Oct 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.